
SI Stock Forecast & Price Target
SI Analyst Ratings
Bulls say
Shoulder Innovations Inc. demonstrated an increase in the addition of surgeons during the second quarter of 2025, surpassing initial projections and leading to an adjusted growth estimate of approximately 11 new Core Contender surgeons per quarter. The company's revenue estimates for the quarter reached $11.0 million, buoyed by stronger-than-expected average selling prices (ASPs), which were positively influenced by product mix. With a strengthened balance sheet and significant market opportunities available, Shoulder Innovations is well-positioned to enhance its commercial initiatives and achieve robust top-line growth in the coming periods.
Bears say
Shoulder Innovations Inc faces multiple challenges that contribute to a negative outlook on its stock, primarily rooted in slower than anticipated product adoption by new surgeons and lower growth projections for the overall shoulder market. The company has reported a significant EBITDA loss of $35.9 million, indicating substantial financial strain and a need for operational improvements. Additionally, potential issues such as faster average selling price degradation, delayed market expansion, and increased operating expenses pose further risks to the company's financial health and growth trajectory.
This aggregate rating is based on analysts' research of Shoulder Innovations LLC and is not a guaranteed prediction by Public.com or investment advice.
SI Analyst Forecast & Price Prediction
Start investing in SI
Order type
Buy in
Order amount
Est. shares
0 shares